FDA Investigator Randy L Clarida

Randy L Clarida has conducted inspections on 438 sites in 5 countries as of 27 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
438
Last Inspection Date:
27 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Netherlands, Canada, Puerto Rico, Cuba
FDA Investigators that have inspected at least one site in common with Randy L Clarida:
Aaron P Wozniak, Abby Lmozeke Baker, Abdur Rashid, Adam R Cooke, Alaric C Denton, Amanda L Evanco, Amy A Johnson, Amy C Amaro, Amy H Ruble, Ann B Borromeo, Anna E Fain, Annette Melendez, Anthony J Grace, April R Bowen, Arie R Dyk, Arthur G Hurst, Babatunde D Babalola, Barbara D Wright, Barbara G Peoples, Barbara M Frazier, Barbara T Carmichael, Bernadette T Tallman, Betsy C Galliher, Billi Jom Johnson, Billy M Battles, Bonita S Chester, Brandon C Heitmeier, Brandy D Brown, Brentley S Collins, Brian A Graves, Brian R Yaun, Brian S Lynch, Bryan J Love, Burnell M Henry, Cara M Minelli, Carl E Lovrich, Carlos A Ortiz, Carlos M Gonzalez, Carol F Robinson, Carol J Blackwood, Carrie L Doupnik, Cassandra L Abellard, CDR Thomas R Berry, PPh, Charanjeet Jassal, Charles D Boison, Chateryl K Washington, Cherrie A Zachary, Cheryl D Barton, Cheryl L Watson, Chris Alexander, Christian D Lynch (CDL), Christie B Rice, Christopher B May, Christopher J Adams, Christopher S Keating, Claire M Minden, Claudele S Razo, Claudette D Brooks, Cody D Rickman, Constance Y Fears, Cordelia J Brammer, Courtney A Gilbert, Craig A Garmendia, Cynthia Jim, CSO, Cynthia L Medlin, Dale A Nyberg, Dana M Klimavicz, Daphne Santiago, PhD, David E Lowe, David L Chon, David P Moorhead, David T Glover, Davis, Dawn M Braswell, Debra J Tucker, Decarlos A Gomez, Dellarese L Herbert, Dennis L Doupnik, Derek C Price, Devaughn Edwards, Deyaa Shaheen, Diane Hall, Donald C Obenhuber, PhD, Donna D Gallien, MPH, Doretha M Tonkins, Doretha M Wilson, Douglas A Campbell, Douglas L Page, Dr. Sriram Subramaniam, PhD, Eddie J Rigsby, Edecia A Richards, Edward A Brunt, Edward Deberry, Eileen J Bannerman, Ekaterina Allen, Elizabeth D Connell, Elizabeth E Hart (ASCP), MT, Emily E Smith, Erin C Hill, Erin Hill (EH), Erin M Mcdowell, Ernest H Blackwood, Esra Toussaint, Fabian Nchaparro Rodriguez, Gabriel R Mclemore, Gail L Katz, Gamal A Norton, Gary E Coleman, Jr, REHS, Gates E Raynor, Gerald Mierle, German Rivera, Gideon N Esuzor, Gregory S Larson, Hai Lient Phung, Heather Akleimola Hulbert, Heather M Bullock, Heather M Wheeler, Hector A Carrero, Helen R Bester, Henry E Sanchez, Hoimay Chan, Holly M Scott, Hristu B Chepa, Ibad U Khan, Igbinoba, Inga M Warr, Ivan E Reyes, Jacqueline Mdiaz Albertini, James C Maclaughlin, James P Lewis, Jr, Jana L Caylor, Janet B Gray, Jared P Stevens, Jason D Abel, Jason F Chancey, Jason K Morgan, Jawaid Hamid, Jeff M Uriarte, Jennifer D Hollstrom, Jennifer L Custodio, Jessica A Stephens, Jessica D Weber, Jessica Fields, Jessica L Johnson, Joe A Odom, John D Lloyd, John E Aghadia, Johnathan M Crayton, Johnson, Jorge E Martinez, Jose A Moreno, Jose Acruz Gonzalez, Joseph F Owens, Juanelma H Palmer, Kara D Dobbin, Kara D Miller, Karen M Labounty, Kassa Ayalew, MD, Katelynn J Rollins, Kathleen D Culver, Kelley L Clark, Kellie L Thommes, RN, Kellie L Westerbuhr, Kemejumaka N Opara, Kenneth L Smalls, Kenneth R Merritt, Kenny R Robinson, Kimberly Cdelk Brooks, Kip J Hanks, Konsuela Y Glass, Laiza V Garcia, Laressa R Gray, Larry K Hampton, Laura D Cain, Laura E Garcia, Laurel A Beer, Laurimer Kuilan Torres, Lauryl A Smith, Lawrence Carter, III, Lawrence Thomas, LCDR Randall L Morris, Leena Thomas, Lequita M Mayhew, Leslie W Gilbert, Libia M Lugo, Lily Y Koo, Linda A Gregory Duty, Lourdes Andujar, LT Daveta L Bailey, Luis A Carrion, Luis Soto Lopez, Lura D Baquero, Lura D Kelly, Lynda L Lanning, Mancia R Walker, Marcia A Worley, Marie F Morin, Mark W Rivero, Marla A Cassidy, Martrice A Packer, Mary Alice Papadimitriou, Mary T Carden, Melanie L Drayton, Melanie M Walker, Melissa D Kalik, Mercy O Quagraine, Metitia G Sanders, Metitia M Gramby, Michael F Skelly, PhD, Michael T Nehring, Michele Howard, Michele L Forster, PhD, Michelle D Haamid, Michelle L Jones, Michelle Yclark Stuart, Miriam Montes, Mizanne E Lewis, Monica Cburgos Garcia, Morrell, Myla D Chapman, Nancy E Fontaine, Nancy L Meade, Nancy L Neiger, Nancy T Waites, Narong Chamkasem, PhD, Nicholas M Smith, Nicole K Trudel, Nicole M Bell, Nimmy Mathews, Noreen Muñiz, Omotunde O Osunsanmi, Pablo Feliciano, Pamela L Velez Vega, Patricia F Hudson, Paula J Bretz, Penny H Mccarver, Perry H Gambrell, Philip F Istafanos, DMV, MS, Prabhu P Raju, Radona R Boutte, Randa Melhem, PhD, Randy D Baxter, Rashard A Knight, Rashonda N Rucker, Reba A Gates, Rhonda Alexander, Richard J Bashay, Richard K Vogel, Richard L Bartlett, Richard L Garcia, Robert C Coleman, Robert W Turner, Robin N Goins, Ronnie E Jackson, Rose Ashley, Rose Xu, Rosia E Nesbitt, Russell R Zablan, Samantha J Pinizzotto, D V M, Samuel A Hamblin, Sandra I Gaul, Sandra R Saunders, Sandra Sejdinovic, Sara Ann R Brown, Sarah C Pichette, Saundrea A Munroe, Sayeeda Hdabe, Scott T Ballard, Seneca D Toms, Shafiq S Ahadi, Sharpe, Shayla G Turnipseed, Shelley H Beausoleil, Sheri S Oliver, Shusheen A Alexander, Sondra M Rates, Sonya M Edmonds, Srinivas R Chennamaneni, PhD, Stardust W Mazzariello, Stephanie Harrell, Stephen G Mclane, Steven D Banks, Sukhanya Jayachandra, Susan M Jackson, Susan O Oladeji, Tajah L Blackburn, Tamara M Casselman, Tamika D Cathey, Tamika E Allen, RN, Tammara A Stephens, Thao Le, Theressa B Smith, Thomas D Clarida, Thomas Finn, PhD, Thomas R Withers, Traci M Armand, Tracy R Ball, Travis R Hunt, Travis S Bradley, Valerie Jgrecek Trinh, Verdell Nelson, Vicky C Stoakes, Vincent M Williams, Viviana Matta, Weedb, William P Tonkins, Young Kim, Yun Wu, PhD, Zachary J Conlin, Zhong Li, PhD

Randy L Clarida's Documents

Publish Date Document Type Title
September, 2021 FDA 483 Fenwal International, Inc. - Form 483, 2021-09-24
August, 2003 EIR GlaxoSmithKline - EIR, 2003-08-07
July, 2012 FDA 483 LifeSouth Community Blood Centers, Inc. - Form 483, 2012-07-24
March, 2023 FDA 483 D. D. Eisenhower Army Med. Ctr. - Blood Bank - Form 483, 2023-03-24
February, 2024 FDA 483 Cone Health - Form 483, 2024-02-27
June, 2004 EIR BRT- Burleson Research Technologies - EIR, 2004-06-25
June, 2008 FDA 483 Hospira, Inc. - Form 483, 2008-06-13
May, 2009 FDA 483 Walter L. Shepeard Community Blood Center, Inc. - Form 483, 2009-05-15
February, 2008 FDA 483 Span Packaging Services LLC dba Multi-Pack Solutions - Form 483, 2008-02-19
September, 2022 FDA 483 LifeShare Blood Center - Form 483, 2022-09-01
May, 2024 FDA 483 Novant Health Forsyth Medical Center - Form 483, 2024-05-02
July, 2008 FDA 483 Deb-STOKO USA LLC - Form 483, 2008-07-25
July, 2019 FDA 483 Creative Testing Solutions - Form 483, 2019-07-16
November, 2017 EIR Plakous Therapeutics, Inc - EIR, 2017-11-14
March, 2004 FDA 483 North Carolina State University- Laelom - Form 483, 2004-03-26
March, 2004 EIR North Carolina State University- Laelom - EIR, 2004-03-26
January, 2020 EIR CSL Plasma Inc - EIR, 2020-01-22
July, 2005 EIR Patheon Manufacturing Services LLC - EIR, 2005-07-29
May, 2009 FDA 483 Dudley Products Inc - Form 483, 2009-05-01
April, 2014 EIR Wilkes Regional Medical Center - EIR, 2014-04-14
April, 2002 EIR Ward, Walter, A., Dr. - EIR, 2002-04-29
May, 2009 EIR Walter L. Shepeard Community Blood Center, Inc. - EIR, 2009-05-15
May, 2004 EIR Catalent Pharma Solutions, LLC - EIR, 2004-05-28
June, 2012 EIR The American National Red Cross - Southern Region - EIR, 2012-06-29
June, 2010 EIR The American National Red Cross - Southern Region - EIR, 2010-06-11
May, 2023 FDA 483 CorneaGen Inc. - Form 483, 2023-05-31
April, 2010 FDA 483 Ajinomoto Health & Nutrition North America, Inc. - Form 483, 2010-04-13
April, 2019 FDA 483 Danville Regional Medical Center - Form 483, 2019-04-25
November, 2012 EIR American Red Cross - EIR, 2012-11-16

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more